


To secure capital growth from a portfolio of securities of companies engaged in Health and Pharmaceuticals and Biotechnology.
| Latest Price | 89.49p | IMA Sector | Specialist | 
|---|---|---|---|
| Currency | British Pound | Launch Date | 21/11/2000 | 
| Fund Size | £32.28m | Fund Manager | Ali Toutounchi | 
| ISIN | GB0001955318 | Dividend | 0.78p | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 89.49p | 
| Currency | GBP | 
| Change | 0.97p | 
| % | 1.10% | 
| YTD change | -6.90p | 
| YTD % | -7.16% | 
| Fund Inception | 21/11/2000 | 
|---|---|
| Fund Manager | Ali Toutounchi | 
| TER | 1.15 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.00% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | -0.09 | 
You are here: research